Benjamin Y. Fong is Honors Faculty Fellow at Barrett, the Honors College and Associate Director of the Center for Work & Democracy at Arizona State University.
He is the author of Quick Fixes: Drugs in America from Prohibition to the 21st Century Binge (Verso 2023). He is also the co-editor (with Craig Calhoun) of The Green New Deal and the Future of Work (Columbia, 2022) and the author of Death and Mastery: Psychoanalytic Drive Theory and the Subject of Late Capitalism (Columbia, 2016). His writing can be found in Jacobin, Catalyst, The New York Times, Current Affairs, The Point, and other popular outlets, and it is collected at benfong.com.
Drugmaker Lykos Therapeutics announced on Aug. 9, 2024, that the Food and Drug Administration declined to approve the company’s application for the use of MDMA-assisted therapy in the treatment of post-traumatic stress disorder.
Drugmaker Lykos Therapeutics announced on Aug. 9, 2024, that the Food and Drug Administration declined to approve the company’s application for the use of MDMA-assisted therapy in the treatment of post-traumatic stress disorder.
This is your last chance to secure discounted registration to both national seminars before prices increase on Monday! You're invited to attend Australia's most popular seminars for GPs and healthcare professionals.
TONIGHT! The new dementia test - Assessment & management of the patient with cognitive concerns
Tuesday 3rd February, 7pm - 9pm AEDT
Speaker
Dr Stephanie Daly
General Practitioner; GP Educator, Dementia Training Australia; Central Adelaide Multi-Disciplinary Geriatric Service, SA Health
We invite you to our first webcast of 2026, where Dr Stephanie Daly will provide an update on dementia tests in primary care. Earn up to 4 hours CPD. RACGP & ACRRM accredited.
Clinical Articles
